Histopathological alterations in mice under sub-acute treatment with Hintonia latiflora methanolic stem bark extract

• Nancy G. Flores-Jiménez ^[1] ; Marcela Rojas-Lemus ^[1] ; Teresa I. Fortoul ^[1] ; Armando Zepeda-Rodríguez ^[1] ; Perla Y. López-Camacho ^[2] ; Jhony Anacleto-Santos ^[2] ; Filiberto Malagón Gutiérrez ^[1] ; Gustavo Basurto-Islas ^[3] ; Norma Rivera-Fernández ^[1]
  1. [1] Universidad Nacional Autónoma de México

     Universidad Nacional Autónoma de México

     México

     
  2. [2] Universidad Autónoma Metropolitana

     Universidad Autónoma Metropolitana

     México

     
  3. [3] Universidad de Guanajuato

     Universidad de Guanajuato

     México

     

  Mostrar afiliaciones +
• Localización: Histology and histopathology: cellular and molecular biology, ISSN-e 1699-5848, ISSN 0213-3911, Vol. 33, Nº. 12, 2018, págs. 1299-1309
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • The indiscriminate use of herbal products is increasingly growing worldwide; nonetheless consumers are not warned about the potential health risks that these products may cause. Hintonia latiflora (Hl) is a tree native to the American continent belonging to the Rubiaceae family and its stem bark is empirically used mainly to treat diabetes and malaria; supplements containing Hl are sold in America and Europe without medical prescription, thus scientific information regarding its toxicity as a consequence of a regular consumption is needed. In the present study, the histopathological effect of 200 and 1000 mg/kg of Hl methanolic stem bark extract (HlMeOHe) was evaluated in the small bowel, liver, pancreas, kidneys and brain of CD-1 male mice after oral sub-acute treatment for 28 days. No histopathological alterations were observed in the brain of the treated animals;

    however, mice presented diarrhea from day 2 of treatment with both doses. No histological changes were observed in the tissues collected from the animals treated with 200 mg/kg, except for the liver that depicted periportal hepatitis. Animals treated with the higher dose showed in the liver sections hydropic degeneration, hepatitis and necrosis small bowel sections showed dilated mucosal vessels, kidney sections depicted tubular necrosis and in pancreas sections, hydropic degeneration of the pancreatic islets was observed. In conclusion, HlMeOHe damaged the liver with an oral dose of 200 mg/kg, and at 1000 mg/kg injured the kidneys and pancreas of the CD1 male mice.